- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04754633
Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines
February 12, 2021 updated by: Seyhmus Kavak
Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines: Correlation Between Radiologists
To present the first admission chest computed tomography (CT) findings of patients followed up with a diagnosis of COVID-19, and to compare the two classification systems by evaluating these findings according to the BSTI and RSNA guidelines.
Study Overview
Status
Completed
Conditions
Detailed Description
A total of 764 adult patients who were diagnosed with COVID-19 inpatient of researchers' hospital 2020 were included in this study.
The findings were recorded as typical, indeterminate, and atypical by the RSNA guidelines and as classical COVID-19, possible COVID-19, indeterminate, and non-COVID-19 by the BSTI classification.
The data obtained according to both classification systems were compared with each other.
Study Type
Observational
Enrollment (Actual)
764
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Diyarbakır, Turkey, 21600
- Sağlik Bilimleri Üniversitesi Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Subjects who applied to the emergency department with the diagnosis of COVID-19 and had chest CT examination between 07.01.2020 and 07.20.2020.
Description
Inclusion Criteria:
- Who had single negative RT-PCR
- Non-optimal chest CT , insufficient data
- <18 age of year
- Thoracic trauma
- Chest CT Negative
Exclusion Criteria:
- RT-PCR positive and chest CT positive findings
- At least two RT-PCR negative and chest CT positive findings
- >18 age of year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Current study evaluating the success of the guidelines recommended by RSNA and BSTI in detecting COVID-19 disease
Time Frame: 1st week from the moment of first admission
|
Kappa correlation analysis was performed between radiologists in the evaluation of chest CT findings of COVID-19 disease according to BSTI and RSNA guidelines.
|
1st week from the moment of first admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Actual)
July 20, 2020
Study Completion (Actual)
July 20, 2020
Study Registration Dates
First Submitted
February 10, 2021
First Submitted That Met QC Criteria
February 12, 2021
First Posted (Actual)
February 15, 2021
Study Record Updates
Last Update Posted (Actual)
February 15, 2021
Last Update Submitted That Met QC Criteria
February 12, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020/588
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted